NOVARTIS
Novartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide. Their mission is to discover new ways to improve and extend people's lives. They apply their expertise in science and innovation to society’s biggest health challenges. Responsibility is a core part of their business strategy.
NOVARTIS
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
1996-01-01
Address:
Basel, Basel-Stadt, Switzerland
Country:
Switzerland
Website Url:
http://www.novartis.com
Total Employee:
10001+
Status:
Active
Contact:
+41 61 324 11 11
Total Funding:
6.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API LetsEncrypt Google Tag Manager WordPress Content Delivery Network Font Awesome Domain Not Resolving Wordpress Plugins
Similar Organizations
Abomics
Abomics Ltd is an expert company that promotes the application of medical research to patient care.
Adastra Pharmaceuticals
Adastra Pharmaceuticals provides responsible solutions to advance patient care in oncology.
Antidote.me
Antidote is a digital health company that accelerates and improves medical research by combining technologies, data, and business models.
Vero Biotech
Vero Biotech is a biopharmaceutical company that commercializes inhaled nitric oxide delivery systems for healthcare providers.
MedCompared
MedCompared is a health comparison site that helps you to choose your prescribed medication for the best price in the best online pharmacy.
NeoGenomics
NeoGenomics is a cancer reference laboratory that provides cancer testing and partnership programs to pathologists and oncologists.
Novartis India
Novartis India is a healthcare company that address needs and deliver better patient outcomes.
Novo Nordisk
Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care.
PharmaLead
PharmaLead is a healthcare company that advises and improves pharmacies in the re-design of business processes and business operations.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Current Advisors List
Board_member
2013-01-01
Board_member
2012-02-01
Board_member
2015-02-01
Board_member
2013-08-01
Board_member
2013-01-01
Board_member
2021-02-01
Advisor
2021-04-01
Board_member
Current Employees Featured
Peggy Carter Director Regulatory Affairs @ Novartis
Director Regulatory Affairs
2011-01-01
Michelle Chernock Therapeutic Area Head for Neuroscience @ Novartis
Therapeutic Area Head for Neuroscience
Dejan Arzensek Senior Manager @ Novartis
Senior Manager
2021-04-01
Bruno Villetelle Global Head of Data & Digital @ Novartis
Global Head of Data & Digital
2019-04-01
Mirjam Neelen Head of Global Learning Design & Learning Sciences @ Novartis
Head of Global Learning Design & Learning Sciences
2020-08-01
Sonja Catrin Fabian Global Head Talent Management & Leadership, Sandoz @ Novartis
Global Head Talent Management & Leadership, Sandoz
2018-02-01
Shahram Ebadollahi Chief Data and AI Officer @ Novartis
Chief Data and AI Officer
2021-04-01
Justin Rauschkolb Associate Director, Digital Marketing - HCP Media @ Novartis
Associate Director, Digital Marketing - HCP Media
2019-12-01
Lou Galli Senior Solutions Architect @ Novartis
Senior Solutions Architect
2010-06-01
Flemming Ornskov Team Member @ Novartis
Team Member
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-12-22 | Gyroscope Therapeutics | Gyroscope Therapeutics acquired by Novartis | 1.5 B USD |
| 2021-09-17 | Arctos Medical | Arctos Medical acquired by Novartis | N/A |
| 2021-06-01 | Cellerys | Cellerys acquired by Novartis | N/A |
| 2020-12-17 | Cadent Therapeutics | Cadent Therapeutics acquired by Novartis | 770 M USD |
| 2020-10-29 | Vedere Bio ll | Vedere Bio ll acquired by Novartis | 280 M USD |
| 2020-04-20 | Amblyotech | Amblyotech acquired by Novartis | N/A |
| 2019-11-24 | The Medicines Company | The Medicines Company acquired by Novartis | 9.7 B USD |
| 2019-05-09 | Xiidra | Xiidra acquired by Novartis | 1.9 B USD |
| 2018-12-21 | CellforCure | CellforCure acquired by Novartis | N/A |
| 2018-10-18 | Endocyte | Endocyte acquired by Novartis | N/A |
Investors List
Bill & Melinda Gates Foundation
Bill & Melinda Gates Foundation investment in Grant - Novartis
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-08-25 | Aktis Oncology | Novartis investment in Series A - Aktis Oncology | 84 M USD |
| 2022-07-25 | Cleerly | Novartis investment in Series C - Cleerly | 223 M USD |
| 2022-06-22 | Alladapt Immunotherapeutics | Novartis investment in Venture Round - Alladapt Immunotherapeutics | 119 M USD |
| 2022-05-19 | Deciphex | Novartis investment in Series B - Deciphex | 11.5 M USD |
| 2022-03-04 | Klarah | Novartis investment in Grant - Klarah | 20 K USD |
| 2022-03-04 | Parrots | Novartis investment in Pre Seed Round - Parrots | 100 K USD |
| 2021-12-07 | Freenome | Novartis investment in Series D - Freenome | 300 M USD |
| 2021-12-06 | Holmusk | Novartis investment in Venture Round - Holmusk | N/A |
| 2021-12-02 | Medtech Africa | Novartis investment in Grant - Medtech Africa | 20 K USD |
| 2021-11-09 | Mekonos | Novartis investment in Series A - Mekonos | 25 M USD |
Newest Events participated
Participated in Webit Festival Europe
on 2020-06-17 as sponsor
Key Employee Changes
Official Site Inspections
http://www.novartis.com Semrush global rank: 104.19 K Semrush visits lastest month: 941 K
- Host name: 104.18.0.16
- IP address: 104.18.0.16
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Novartis"
Novartis Organizational Structure
Novartis organizational structure Last updated: March 2025 ECN Members. Kees Roks. Chief Audit Officer. Michelle Weese. Chief Corporate Affairs Officer. Rob Kowalski. Chief People & …See details»
Novartis announces new organizational structure to
Apr 4, 2022 Novartis Investor Relations Central investor relations line: +41 61 324 7944 E-mail: investor.relations@novartis.comSee details»
Novartis - Wikipedia
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Consistently ranked in the global top five, Novartis is one of the largest pharmaceutical companies in the world and was the fourth largest by revenue in 2022. Novartis manufactures the drugs clozapine (Clozaril), diclofenac (Voltaren; sold to See details»
Novartis
Mar 28, 2025 Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and …See details»
Novartis - The Org
Novartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide. Industries. Pharmaceutical. Headquarters. Basel, Switzerland. Employees. 10,000+ …See details»
Novartis announces new organizational structure - World Pharma …
Apr 5, 2022 The elevation and establishment of an independent US commercial organization strengthens Novartis’s ability to achieve its goal of becoming a top-five company in the US in …See details»
Novartis Org Chart + Executive Team - The Official Board
The organizational chart of Novartis displays its 541 main executives including Vasant Narasimhan, Harry Kirsch and Richard Saynor. Toggle navigation The Official Board. Search. Search. Search by segment. Sign In. Business E-mail* …See details»
Novartis changes organizational structure to save at …
Apr 4, 2022 The elevation and establishment of an independent US commercial organization strengthens Novartis’s ability to achieve its goal of becoming a top-five company in the US in terms of sales while maintaining and growing its …See details»
Novartis unveils major re-org | Pharma Manufacturing
Apr 4, 2022 Novartis has announced a new organizational structure and operating model, with an eye on innovation and growth — as well as targeted savings of at least $1 billion by 2024.. …See details»
Novartis announces new organizational structure to accelerate …
Apr 4, 2022 Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales break down by therapeutic area as follows: - …See details»
Novartis - Leadership Team - The Org
The Leadership Team at Novartis plays a crucial role in guiding the company's strategic vision and operational execution in the global healthcare landscape. Comprised of senior executives …See details»
Novartis announces new organizational structure to accelerate …
Apr 4, 2022 Novartis Pharma AG. Ad hoc announcement pursuant to Art. 53 LR. New simplified structure and operational set-up supports Novartis strategy as a focused medicines company …See details»
Novartis announces new organizational structure
Apr 5, 2022 The elevation and establishment of an independent US commercial organization strengthens Novartis’s ability to achieve its goal of becoming a top-five company in the US in …See details»
Novartis Foundation
The Novartis Foundation focuses on the world’s most pressing health challenges: cardiovascular disease and health inequity. We take a population health approach, which means widening the …See details»
Novartis plans to expand its US-based manufacturing and R&D …
13 hours ago Novartis is the only organization with a dedicated commercial RLT portfolio, and has established global expertise, with specialized supply chain and manufacturing capabilities …See details»
Company overview - Novartis
Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are …See details»
Swiss drugmaker Novartis to invest $23bn in US manufacturing …
32 minutes ago Swiss pharma group Novartis has said it will expand its US manufacturing and research and development with a $23bn investment over five years, as drugmakers …See details»
Novartis AG Announces the Introduction of A New Organizational ...
Apr 4, 2022 The elevation and establishment of an independent US commercial organization strengthens Novartis's ability to achieve its goal of becoming a top-five company in the US in …See details»
Novartis to lay off 427 staffers amid marketing model rework
Mar 18, 2025 Entresto, approved in heart failure since 2015, has long been one of Novartis’ top growth drivers, bringing home $4.05 billion in U.S. sales in 2024.See details»
Novartis Pledges $23 Billion US Investment as Tariffs Loom
13 hours ago Swiss pharmaceutical giant Novartis AG said it would invest $23 billion in the US over the next five years to ensure all its key drugs for Americans are made in the country, …See details»